Evaluation of the Efficacy and Safety of a Loop Stretchable Dental Floss

Last updated: October 16, 2024
Sponsor: Indiana University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Periodontitis

Treatment

Brushing and Flossing of teeth

Brushing Only

Clinical Study ID

NCT06515483
22752
  • Ages 18-65
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

This will be a single-blind, single-center, parallel, randomized controlled clinical trial to evaluate the efficacy and safety of Floss Loops stretchable floss for the control of gingivitis and supragingival plaque removal between two groups, control (no-floss) and experimental (flossing with Floss Loops), during thirty (2 +/-) days.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Female and Male subjects between 18 to 65 years old

  • Willing to read and sign the IRB-approved informed consent

  • Healthy, as determined by pertinent medical history at the examiner dentist'sdiscretion

  • A minimum of 20 natural teeth (excluding third molars) with at least two scorablesurfaces per tooth (teeth with full crowns, large/extensive restorations on theinterproximal areas, and orthodontic bands will not be included in the tooth count)

  • Mild to moderate plaque and gingivitis GI of 1.75 or greater (The Lobene-modifiedgingival index score) calculation made based on a whole mouth score

  • PLI of 1.95 or greater (Turesky modification of the Quigley and Hein Plaque Index)calculation based on a whole mouth plaque score

  • Be willing to comply with study visits and requirements

Exclusion

Exclusion Criteria:

  • Presence of any acute or chronic condition, organ system disease, or medicationthat, in the principal investigator's opinion, could compromise the subjects'ability to participate in the study

  • Gross oral pathologies, including caries, calculus, or soft tissue conditions thatshow evidence of chronic neglect

  • Orthodontic appliances appliances (except for fixed lingual retainers, teeth will beexcluded from the teeth count) or any removable prosthesis

  • Evidence of acute periodontal conditions or periodontitis with pockets greater than 5 mm on more than one site

  • Taking antibiotics two weeks before baseline procedures and throughout the study

  • Need for antibiotic prophylaxis prior to dental procedures

  • Use of daily anti-inflammatory drugs (NSAID, TNF- AB, others) within 30 days beforebaseline

  • Pregnant, wanting to get pregnant, or breast-feeding female

  • Acute Temporomandibular Disorders (TMD)

  • Subject who has participated in other studies (including non-medicinal studies)involving product(s) within 30 days before study entry

  • Subject who has previously been randomized in this study

  • Self-reported allergy to disclosing solution ingredients (red dye #28)

  • An employee of the study site directly involved with the study

Study Design

Total Participants: 64
Treatment Group(s): 2
Primary Treatment: Brushing and Flossing of teeth
Phase:
Study Start date:
October 15, 2024
Estimated Completion Date:
January 30, 2025

Study Description

At the screening/baseline visit, potential subjects will be given the IRB-approved informed consent form to read and ask questions. After the subject signs and dates the consent, the study representative will sign and date the consent to confirm that the consent process was completed before initiating any study procedures. The subject will be given a copy of the signed consent. The study dentist will collect and review information related to the subject's demographic, medical, and concomitant medications. The subject will have a hard and soft tissue exam, as well as a clinical examination of the gums and dental plaque present using the Lobene modified gingival index for gingivitis assessment, the marginal bleeding on probing index and the Turesky modification of the Quigley and Hain plaque index.

A total of 64 subjects who meet the study criteria will be enrolled and randomized into two groups. 32 subjects will be assigned to the control group (Brushing twice a day only and no flossing) and 32 to the experimental group (Brushing and Flossing with the stretchable loop floss twice daily). Each subject will be instructed to clean their teeth daily using only the provided toothbrush with an assigned ADA-accepted fluoride dentifrice. Subjects assigned to the control group will brush their teeth at least twice a day only, and subjects in the experimental group will brush and floss with the provided stretchable loop floss at least twice a day. To assess compliance, each subject will be asked to fill out a diary every time they brush/floss. On day 15 (+/- 2) day of product use, subjects will receive a phone call from the study coordinator or designee to assess brushing/flossing compliance. At day 30 (+/- 2), study hygiene and gum chewing restrictions as well as eating restriction will apply, and the efficacy assessments will be repeated, subjects will be dismissed, and the study will finish.

All clinical examinations will be performed by examiners who will be blind to the subject's oral hygiene procedures.

Connect with a study center

  • Indiana University School of dentistry, Oral Health Research institute 415 Lansing Street

    Indianapolis, Indiana 46202
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.